Compare SANA & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SANA | DGICA |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.1M | 714.2M |
| IPO Year | 2021 | 1995 |
| Metric | SANA | DGICA |
|---|---|---|
| Price | $3.15 | $19.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $7.80 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 2.7M | 97.4K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | ★ 17.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $978,014,322.00 |
| Revenue This Year | N/A | $2.26 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.61 | $16.11 |
| 52 Week High | $6.55 | $21.06 |
| Indicator | SANA | DGICA |
|---|---|---|
| Relative Strength Index (RSI) | 34.27 | 54.78 |
| Support Level | $3.00 | $19.19 |
| Resistance Level | $3.43 | $19.42 |
| Average True Range (ATR) | 0.23 | 0.47 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 8.23 | 65.75 |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.